Source: Applied DNA Sciences Inc

Applied DNA Sciences to Present at SAE Event

White Paper Offered at Counterfeit Parts Avoidance Symposium, November 2, 2012 in Phoenix, AZ

STONY BROOK, NY--(Marketwire - Oct 4, 2012) - Applied DNA Sciences, Inc. (OTCBB: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today it has been invited to present at the important SAE International 2012 Counterfeit Parts Avoidance Symposium. The Symposium will take place on Friday, Nov. 2, 2012 in Phoenix, Arizona. APDN will present an important white paper which Dr. James A. Hayward, APDN CEO and President, calls "a significant contribution to an urgent conversation and a call to action."

The speakers line-up for the Symposium includes thought leaders from throughout the industries impacted. SAE International (SAE) is a global association of more than 128,000 engineers and related technical experts in the aerospace, automotive and commercial-vehicle industries.

SAE has played a key role in the development of industry and government standards in the effort to stem counterfeits in electronics and aerospace. In 2009, the U.S. Department of Defense officially adopted SAE International's standard SAE AS5553-Counterfeit Electronic Parts; Avoidance, Detection, Mitigation, and Disposition.

SAE's G-19 Counterfeit Electronic Parts Committee continues to develop and refine the widely-followed anti-counterfeiting standards.

The Symposium takes place at a critical time in the effort against counterfeits. Electronics and aerospace continue to come to grips with new anti-counterfeiting requirements expressed in Section 818 of the National Defense Authorization Act for Fiscal 2012. Section 818 directs the Office of the Secretary of Defense to update the procurement rules and guidelines to account for the new anti-counterfeiting requirements. These updates may come in early October. The rules and guidelines are found in the Defense Federal Acquisition Regulation (DFAR) Supplement to the Federal Acquisition Regulation (FAR).

APDN technology, which uses an engineered botanical DNA marker to assure authenticity of parts, is the centerpiece of a pilot program supported by the Defense Logistics Agency, managed by the LMI consultancy. As of August 7, 2012, the technology is required by DLA for defense contractors providing microcircuits in FSC 5962 to that Agency.

Janice Meraglia, APDN Vice President for Government and Military Programs, commented: "We are honored to present at an event which includes leaders who have made a real difference in the fight against counterfeits, going back many years. We believe our technology platform is poised to become a key tool in this effort, and something which will work well with and contribute to ongoing standards initiatives."

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 8, 2011 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Contact Information:

MEDIA CONTACT:
Mitchell Miller
646-543-3373
fax: 631-444-8848

INVESTOR CONTACT:
Debbie Bailey
631-444-8090
fax: 631-444-8848

FCMN Contact:


PROGRAM CONTACT:
Janice Meraglia:
631-444-6293

Web site: http://www.adnas.com
Twitter: @APDN, @APDNInvestor